Recently, a study came out by Wormser et al. on the efficacy of a 14-day course of amoxicillin for patients with erythema migrans (EM). The study purports to be the first clinical study in the U.S. that validates this regimen but states foreign studies have already done so (1).
Why Mainstream Lyme/MSIDS Research is Stuck in the Dark Ages
Written by Alicia Cashman